Literature DB >> 15806376

Bilateral anterior granulomatous uveitis associated with cutaneous Rosai-Dorfman disease.

Juan G Gaviria1, Daniel A Johnson, Marsha C Kinney, Liana H Proffer, Jacqueline M Losi-Sasaki, Eric W Kraus.   

Abstract

BACKGROUND: Rosai-Dorfman disease (RDD) is a benign, rare, histiocytic disorder of unknown etiology. We describe the case of a 61-year-old woman who presented to the ophthalmology clinic with bilateral granulomatous anterior uveitis.
METHODS: The uveitis was controlled on topical prednisolone acetate 1%. One month after presentation, she developed generalized macules and papules, and dermatologic and systemic evaluations were performed.
RESULTS: On the basis of skin biopsy, purely cutaneous RDD was established.
CONCLUSION: Anterior granulomatous uveitis may be the presenting sign of cutaneous RDD. Consultation is necessary for accurate diagnosis.

Entities:  

Mesh:

Year:  2004        PMID: 15806376     DOI: 10.1007/s00417-004-0993-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  12 in total

1.  Marginal corneal infiltrates: a possible new manifestation of sinus histiocytosis with massive lymphadenopathy.

Authors:  S Rumelt; I Cohen; U Rehany
Journal:  Cornea       Date:  2000-11       Impact factor: 2.651

2.  Rosai-Dorfman disease with bilateral serous retinal detachment.

Authors:  Carsten H Meyer; Saadettin Sel; Steffen Hörle; Jürgen Burg; Peter Kroll
Journal:  Arch Ophthalmol       Date:  2003-05

Review 3.  Cutaneous Rosai-Dorfman disease: remission with thalidomide treatment.

Authors:  J-W Tjiu; C-H Hsiao; T-F Tsai
Journal:  Br J Dermatol       Date:  2003-05       Impact factor: 9.302

4.  Rosai Dorfman disease or sinus histiocytosis with massive lymphadenopathy of the orbit.

Authors:  R Khan; P Moriarty; S Kennedy
Journal:  Br J Ophthalmol       Date:  2003-08       Impact factor: 4.638

5.  Cutaneous sinus histiocytosis and chronic uveitis.

Authors:  J F Silvestre; A Aliaga
Journal:  Pediatr Dermatol       Date:  2000 Sep-Oct       Impact factor: 1.588

6.  Rosai-Dorfman disease presenting as bilateral lacrimal gland enlargement.

Authors:  M Lee-Wing; A Oryschak; G Attariwala; M Ashenhurst
Journal:  Am J Ophthalmol       Date:  2001-05       Impact factor: 5.258

7.  Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism.

Authors:  A Salim; M Williamson; F Barker; J Hughes
Journal:  Clin Exp Dermatol       Date:  2002-06       Impact factor: 3.470

8.  The ophthalmologic manifestations of sinus histiocytosis with massive lymphadenopathy.

Authors:  E Foucar; J Rosai; R F Dorfman
Journal:  Am J Ophthalmol       Date:  1979-03       Impact factor: 5.258

9.  Cutaneous rosai-dorfman disease is a distinct clinical entity.

Authors:  Thomas Brenn; Eduardo Calonje; Scott R Granter; Niamh Leonard; Wayne Grayson; Christopher D M Fletcher; Phillip H McKee
Journal:  Am J Dermatopathol       Date:  2002-10       Impact factor: 1.533

10.  Relapsing bilateral uveitis and papilledema in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease).

Authors:  P Pivetti-Pezzi; C Torce; R A Colabelli-Gisoldi; A Vitale; A Baccari; A Pacchiarotti
Journal:  Eur J Ophthalmol       Date:  1995 Jan-Mar       Impact factor: 1.922

View more
  3 in total

1.  Choroidal involvement in Rosai-Dorfman syndrome may be depicted and followed using enhanced depth imaging optical coherence tomography (EDI-OCT).

Authors:  Timothy William Isaacs; Tersia L Vermeulen; Dominic Spagnolo; Ben Amanuel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-04-01       Impact factor: 3.117

Review 2.  Rosai-Dorfman disease presenting as choroidal melanoma: a case report and review of the literature.

Authors:  Tersia L Vermeulen; Timothy W Isaacs; Dominic Spagnolo; Benhur Amanuel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-10-24       Impact factor: 3.117

3.  Extranodal Rosai-Dorfman of the Pancreas Presents with Bilateral Granulomatous Anterior Uveitis.

Authors:  A'sha Brown; Sara V Branson; Ghazala A Datoo O'Keefe
Journal:  Ocul Oncol Pathol       Date:  2018-10-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.